{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=PReye%2C%20LLC","name":"PReye, LLC","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-11-03T11:28:42.384Z"},"count":1,"matches":[{"id":"ec707776f29097e0","posted_date":"2026-09-01","letter_issue_date":"2026-08-18","company_name":"PReye, LLC","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug","canonical_url":"https://api.morvs.ai/fda-warning/ec707776f29097e0"}]}